Viewing Study NCT00148655



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00148655
Status: COMPLETED
Last Update Posted: 2007-12-28
First Post: 2005-09-07

Brief Title: Educational Interventions for Patients With DCIS
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Study Overview

Official Title: A Randomized Trial for Educational Interventions for Patients With DCIS Actually Making Treatment Decisions
Status: COMPLETED
Status Verified Date: 2007-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether adding an educational intervention in the form of a decision board which outlines the risks and benefits of treatment options for DCIS at the time of the first surgical consultation will improve decision making for women with DCIS
Detailed Description: The decision board explains the risks and benefits of mastectomy excision and radiation excision radiation and tamoxifen excision alone and excision without radiation and tamoxifen for women with DCIS
Patients will receive a decision board to take home for review Two fifteen-minute telephone interviews will be conducted one approximately one week after enrollment and one 2 months after enrollment
In the phone interviews patients will asked to complete a brief survey This survey will ask abou DCIS in general the patients treatment decisions their feelings as well as their experience with the decision board
This study will take about 2 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None